Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis.
Harris VK, Yan QJ, Vyshkina T, Sahabi S, Liu X, Sadiq SA. Harris VK, et al. Among authors: vyshkina t. J Neurol Sci. 2012 Feb 15;313(1-2):167-77. doi: 10.1016/j.jns.2011.08.036. Epub 2011 Oct 1. J Neurol Sci. 2012. PMID: 21962795
Genetic variants of Complex I in multiple sclerosis.
Vyshkina T, Banisor I, Shugart YY, Leist TP, Kalman B. Vyshkina T, et al. J Neurol Sci. 2005 Jan 15;228(1):55-64. doi: 10.1016/j.jns.2004.09.027. J Neurol Sci. 2005. PMID: 15607211
CD45 (PTPRC) as a candidate gene in multiple sclerosis.
Vyshkina T, Leist TP, Shugart YY, Kalman B. Vyshkina T, et al. Mult Scler. 2004 Dec;10(6):614-7. doi: 10.1191/1352458504ms1115oa. Mult Scler. 2004. PMID: 15584483
Lack of mitochondrial DNA deletions in lesions of multiple sclerosis.
Blokhin A, Vyshkina T, Komoly S, Kalman B. Blokhin A, et al. Among authors: vyshkina t. Neuromolecular Med. 2008;10(3):187-94. doi: 10.1007/s12017-008-8025-2. Neuromolecular Med. 2008. PMID: 18286391
Autoantibodies and neurodegeneration in multiple sclerosis.
Vyshkina T, Kalman B. Vyshkina T, et al. Lab Invest. 2008 Aug;88(8):796-807. doi: 10.1038/labinvest.2008.53. Epub 2008 Jun 2. Lab Invest. 2008. PMID: 18521063 Review.
Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis.
Harris VK, Stark J, Vyshkina T, Blackshear L, Joo G, Stefanova V, Sara G, Sadiq SA. Harris VK, et al. Among authors: vyshkina t. EBioMedicine. 2018 Mar;29:23-30. doi: 10.1016/j.ebiom.2018.02.002. Epub 2018 Feb 3. EBioMedicine. 2018. PMID: 29449193 Free PMC article. Clinical Trial.
Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
Harris VK, Vyshkina T, Sadiq SA. Harris VK, et al. Among authors: vyshkina t. Cytotherapy. 2016 Dec;18(12):1476-1482. doi: 10.1016/j.jcyt.2016.08.007. Epub 2016 Oct 7. Cytotherapy. 2016. PMID: 27727015
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
Harris VK, Faroqui R, Vyshkina T, Sadiq SA. Harris VK, et al. Among authors: vyshkina t. Stem Cells Transl Med. 2012 Jul;1(7):536-47. doi: 10.5966/sctm.2012-0015. Epub 2012 Jun 28. Stem Cells Transl Med. 2012. PMID: 23197858 Free PMC article. Clinical Trial.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Kumagai C, Kalman B, Middleton FA, Vyshkina T, Massa PT. Kumagai C, et al. Among authors: vyshkina t. J Neuroimmunol. 2012 May 15;246(1-2):51-7. doi: 10.1016/j.jneuroim.2012.03.003. Epub 2012 Mar 27. J Neuroimmunol. 2012. PMID: 22458980 Free PMC article.
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
Vyshkina T, Sylvester A, Sadiq S, Bonilla E, Canter JA, Perl A, Kalman B. Vyshkina T, et al. Clin Immunol. 2008 Oct;129(1):31-5. doi: 10.1016/j.clim.2008.07.011. Epub 2008 Aug 16. Clin Immunol. 2008. PMID: 18708297 Free PMC article.
16 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback